Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (8) , 1395-1401
- https://doi.org/10.1111/j.1538-7836.2004.00798.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patientsBritish Journal of Surgery, 2003
- Pharmacokinetic and Pharmacodynamic Characterization of a Medium-Molecular-Weight Heparin in Comparison with UFH and LMWHSeminars in Thrombosis and Hemostasis, 2002
- A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparinPathology, 2001
- Use of the Activated Partial Thromboplastin Time for Heparin MonitoringAmerican Journal of Clinical Pathology, 2001
- Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patientsJournal of Cardiothoracic and Vascular Anesthesia, 1996
- Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage.Journal of Clinical Pathology, 1996
- Heparin sensitivity and resistance in the neonate: An explanationThrombosis Research, 1991
- Decreased sensitivity to heparin in vitro in steroid–responsive nephrotic syndromeKidney International, 1987
- Heparin half‐life and sensitivity in normal subjects and in patients affected by deep vein thrombosisEuropean Journal of Clinical Investigation, 1986
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983